Factors affecting adherence to antiretroviral treatment in women with HIV: A sequential mixed model research design
Abstract
Background: HIV/AIDS is affecting more and more women. Adherence to antiretroviral treatment (ART) is decisive for those infected to achieve quality of life.
Purpose: The aim of the present study is to determine the degree of adherence displayed by a group of women with HIV/AIDS and to identify those factors and circumstances which might influence their adherence to ART.
Method: A sequential mixed model research design was applied. The subjects studied consisted of 86 women diagnosed with HIV/AIDS and treated with ART.
Findings and discussion: Qualitative data were collected from 18 of these women. 59.3% of participants were non-adherents. The determining factors for non-adherence were level of education, age, income, as well as personal and/or interpersonal factors such as socio-familial support, perceived stigma, self-stigma and factors related to disease and treatment. Nursing care should take a gender-focused approach towards those psychological and personal factors inherent in the adherence process.
Downloads
References
ONUSIDA. Estadísticas mundiales sobre el VIH de 2017.Hoja informativa- Día Mundial del Sida 2018 [Internet]. 2018 [Citado el 24 de abril de 2020]. Disponible en: http://www.unaids.org/es/resources/documents/2018/UNAIDS_FautSheet
ONUSIDA. Informe mundial ONUSIDA, Informe sobre la epidemia mundial de Sida 2013 [Internet]. 2013[citado 20 de abril de 2020]. Disponible en: www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_es_1.pdf
Centro Nacional de Epidemiología- ISCIII. Vigilancia Epidemiológica del VIH y sida en España: Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Área de Vigilancia de VIH y Comportamientos de Riesgo. [Internet] 2016 [citado 27 de abril de 2020]. Disponible en: www. Isciii/ISCIII/es/contenido/fd-servicios-cientifitecnicos/fdvigilancias-alertas/fdenfermedades/fds-sida/pdfsida/Informe_VIH_SIDA_2016_def.pdf
European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016- HIV/AIDS.Stockholm: ECDC. Stockholm: ECDC; 2016. Disponible en: http:// ecdc.europa.eu/en/healthtopics/aids/surveillance-reports/Pages/Annual-Epidemiological-Report-2016.aspx
Panel de expertos GeSida/ PNS. Recomendaciones de GeSida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana [Internet]. 2018. Disponible en: http://www.gesida-seimc.org/wp-content/uploads/2018/01/gesida_TAR_adultos_v3-1.pdf
Barroso J, Leblanc N, Flores D. It´s not just the pills: A qualitative meta- synthesis of HIV antiretroviral adherence research. J Assoc Nurses AIDS Care. 2017;28(4):462–78. doi: 10.1016/j.jana.2017.02.007.
Shubber Z, Mills EJ, Nachega J b., Al. E. Patient-reported barriers to adherence to antirretroviral theraphy: a systematic review and meta-analysis. PloS Med. 2016;13. doi: 10.1371/journal.pmed.1002183.
Puskas C, Hogg R. Unlocking adherence: is gender the key? Lancet. 2014;2(1). doi: 10.1016/S2352-3018(14)00033-2
Kanters S, Park JJ, K. C. Interventions to improve adherence to antiretroviral theraphy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):31–40. doi: 10.1016/S2352-3018(16)30206-5
UNAIDS. 5 Years since ICPD. 2017. Disponible en: http:// www.unaids.org/publications/documents/human/gender/newsletter.pdf.
Peltzer J, Ogawa L, Tusher S, Farnan R, Gerkovich M. A Qualitative Description of HIV- Infected African American Women´s Experiences of Psychological Distress and Their Coping Strategies. J Ass Nurses AIDS Care. 2017;28(2):226–37. doi: 10.1016/j.jana.2016.09.010.
Rivera M, Varas N, Coriano D, Padilla M, Reyes M. Ellos de la calle, nosotras de la casa: el discurso patriarcal y las experiencias de mujeres que viven con el VIH/SIDA en Puerto Rico. In: La agenda emergente de las ciencias sociales Conocimiento, crítica e intervención (5o Congreso Nacional de Ciencias Sociales). Consejo Me. Madrid; 2015. p. 682–92.
Varela MT, Salazar IC, Correa D, Duarte C, Tamayo JA, Salazar AE. La evaluación integral de la adherencia al tratamiento en mujeres con VIH/SIDA: validación de un cuestionario. Rev Col Med,. 2009;40(4):386–97. doi: 10.15446/rsap.v17n4.38429
Ibarra O, Morillo R. Lo que debes saber sobre la adherencia al tratamiento. Sociedad Española de Farmacia Hospitalaria (SEFH) [Internet]. Boehringer Ingelheim, editor. Badalona; 2017. Disponible en: www.sefh.es/bibliotecavirtual/Adherencia2017/libro_ADHERENCIA.pdf
Limaylla M, Ramos N. Métodos indirectos de valoración del cumplimiento terapéutico. Cienc e Investig. 2016;19(2).
Knobel H, Alonso J, Casado J, Collazos J, González J. Validation of a simplifield medication adherence questionnaire in a large cohort of HIVinfected patients: the GEMMA Study. AIDS. 2002;16(4):605–13. doi: 10.1097/00002030-200203080-00012
Bonner, K., Mezochow, A., Roberts, T., Ford, N.,& Cohn, J. (2013). Viral load monitoring as a toll to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 64(1):74–8.
Panel de expertos GeSida/SPNS. Factores que condicionan el exito del tratamiento antirretroviral. En GeSida/PNS., Documento de consenso de Gesida/Plan Nacional sobre el sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana. Ministerio de Sanidad Servicios Sociales e Igualdad de España. Madrid; 2016. 82–86 p.
Asboe D, Aitken C, Boffito M, Booth C, Cane P. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1 infected individuals. HIV Med. 2011;13(1). doi: 10.1111/j.1468-1293.2011.00971.x
Li L, Lin C, Ji G. Gendered Aspects of Perceived and Internalized HIV- Related Stigma in China. Women Health. 2016;59(7):1031–43. doi: 10.1080/03630242.2016
Valencia- García D, Rao D, Strick L, Simoni J. Women´s experiences with HIV - related stigma from health care providers in Lima, Peru:" I would rather die than go back for care". Heal Care Women Int. 2017;38(2):144– 158. doi: 10.1080/07399332.2016.1217863
Molero F, Fuster M. La influencia del prejuicio y la discriminación. Encuentro FIPSE sobre la investigación de la perspectiva social del VIH/Sida. FIPSE, editor. Asturias; 2006.
Knowlton R, Bohret A, Yang Cui WL, Chande G. Main partner factors associated with worse adherence to HAART among women in Baltimore Maryland: a preleminary study. AIDS Care. 2011;23(9):1102–10. doi: 10.1080/09540121.2011.554516
Caiola C, Barroso J, Sharron L. Black mothers Living with HIV picture the social determinants of health. J Ass Nurses AIDS Care. 2018;29(2):204–19. doi: 10.1016/j.jana.2017.09.011
Garibi C. La compleja relación violencia de género- sida. Un acercamiento a la violencia institucional como factor de vulnerabilidad de las mujeres ante un VIH. Sex salud y Soc. 2009;3:82–105. Disponible en: http://www.insp.mx/salud/index.html
Valls-Llobet C. Manifestaciones y medicalización del malestar en las mujeres. Consumo. Ministerio de Sanidad y Consumo (Observatorio de la Salud de la Mujer) y la Universidad Complutense de Madrid (Grupo de Investigación Estilos Psicológicos, Programa de formadores/as en perspectiva de género en salud. Madrid; 2005.
La Fauri M, Zíñiga M. Mujeres colombianas viviendo con el VIH/Sida: Contextos, experiencias y necesidades de cuidados de enfermería. Enfer Glob. 2011;10(24):317–27. doi: 10.4321/S1695-61412011000400024
Pagès- Puigdemont N, Valverde- Merino MI. Métodos para medir la adherencia terapéutica. ARS Pharm. 2018;59(3). doi:10.30827/ars.v59i3.7387
Ortega Valin L. Adhesión al tratamiento Antirretroviral: Una actualización. In: 2o Seminario de Atención Farmacéutica (Grupo de trabajo de la SEFH) Libro de sesiones. Icono. Madrid; 2002. p. 178–90.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
